Founded in 1996 by Dr. Andrew Thompson, formerly of Merck Research Laboratories in the Department of Process Research, J-STAR Research, Inc. is a contract chemistry organization serving as an outsourcing partner for the biopharmaceutical and biotechnology industry.
Over the past 25 years, J-Star has assembled a team of chemists, scientists and engineers committed to creatively solving complex and matrixed chemistry problems. The emphasis of this support is focused on chemistry-related problem solving centered on Active Pharmaceutical Ingredients and Intermediates in the preclinical and clinical development arena.
While high quality synthetic chemistry and process research services continue to be at J-Star’s foundation, the company has steadily added, and continues to expand, in the areas of Process Chemistry, QC, GMP and QA, Crystallization R&D, Solid Form and Polymorph Screening, Catalysis Screening + Enabling Technology, High Potent Compound Handling (HPAPI), Impurity Isolation and Structural Elucidation, Preformulation & Formulation R&D.
In addition to J-Star’s creative chemistry and engineering problem solving, J-Star has a track record of dependability and flexibility. This ability to adapt to changes within the dynamic preclinical and clinical R&D space, when coupled with J-Star’s unflinching focus to meet objective timelines with rigorous quality, leads to a unique value proposition for your Drug Substance or Drug Product Program.